Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,276 | 681 | 97.9% |
| Education | $152.99 | 3 | 1.2% |
| Travel and Lodging | $111.87 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $2,871 | 208 | $0 (2024) |
| ABBVIE INC. | $2,188 | 103 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $1,078 | 35 | $0 (2024) |
| Janssen Biotech, Inc. | $1,073 | 56 | $0 (2024) |
| QOL Medical, LLC | $672.68 | 45 | $0 (2024) |
| Grifols USA, LLC | $521.59 | 33 | $0 (2024) |
| Ardelyx, Inc. | $460.31 | 34 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $407.70 | 24 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $241.76 | 2 | $0 (2022) |
| Braintree Laboratories, Inc. | $236.62 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,583 | 69 | ABBVIE INC. ($221.36) |
| 2023 | $1,670 | 107 | Janssen Biotech, Inc. ($364.34) |
| 2022 | $1,759 | 93 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($399.55) |
| 2021 | $1,833 | 101 | AbbVie Inc. ($657.14) |
| 2020 | $1,146 | 77 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($544.90) |
| 2019 | $1,244 | 82 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($476.15) |
| 2018 | $1,961 | 84 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($675.32) |
| 2017 | $1,345 | 72 | Valeant Pharmaceuticals North America LLC ($407.70) |
All Payment Transactions
685 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $30.17 | General |
| Category: Rare Disease | ||||||
| 12/10/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.73 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/26/2024 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: GI COLON PREP | ||||||
| 11/26/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: LIVER DISEASE | ||||||
| 11/19/2024 | EVOKE PHARMA, INC. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Rare Disease | ||||||
| 11/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $17.31 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $28.31 | General |
| Category: GI | ||||||
| 10/29/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: LIVER DISEASE | ||||||
| 10/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/16/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $18.27 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $31.41 | General |
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Immunology | ||||||
| 10/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Immunology | ||||||
| 10/02/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Rare Disease | ||||||
| 10/02/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Gastroenterology | ||||||
| 10/01/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.81 | General |
| Category: THERAPY FOR CSID | ||||||
| 09/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 187 | 202 | $109,261 | $25,442 |
| 2022 | 9 | 420 | 583 | $259,020 | $63,896 |
| 2021 | 13 | 763 | 1,053 | $462,231 | $110,929 |
| 2020 | 14 | 754 | 1,125 | $489,070 | $111,446 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $14,766 | $8,218 | 55.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 72 | $12,240 | $6,782 | 55.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 19 | 19 | $22,724 | $5,594 | 24.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 25 | 25 | $29,900 | $2,612 | 8.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 17 | 17 | $29,631 | $2,235 | 7.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 114 | $19,435 | $11,384 | 58.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 42 | 170 | $38,760 | $10,447 | 27.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 73 | 77 | $34,727 | $9,099 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $13,054 | $7,630 | 58.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 22 | 22 | $26,312 | $6,390 | 24.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 18 | 18 | $31,374 | $5,005 | 16.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 36 | 37 | $44,252 | $4,009 | 9.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 40 | 41 | $5,945 | $3,687 | 62.0% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2022 | 15 | 15 | $13,605 | $2,784 | 20.5% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 17 | 17 | $29,631 | $2,457 | 8.3% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2022 | 11 | 11 | $1,925 | $1,004 | 52.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 189 | 209 | $94,259 | $24,731 | 26.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 91 | 313 | $71,364 | $19,537 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 76 | 96 | $16,214 | $9,995 | 61.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 76 | 76 | $16,934 | $9,853 | 58.2% |
| 43246 | Insertion of stomach tube using an endoscope | Facility | 2021 | 43 | 50 | $45,350 | $9,165 | 20.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 75 | 87 | $12,615 | $7,609 | 60.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 65 | 65 | $77,740 | $7,508 | 9.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Office | 2021 | 26 | 26 | $31,096 | $7,150 | 23.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 16 | 16 | $27,888 | $5,076 | 18.2% |
About Dr. Jose Martinez, M.D
Dr. Jose Martinez, M.D is a Gastroenterology healthcare provider based in Hialeah, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1508853490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Martinez, M.D has received a total of $12,541 in payments from pharmaceutical and medical device companies, with $1,583 received in 2024. These payments were reported across 685 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($12,276).
As a Medicare-enrolled provider, Martinez has provided services to 2,124 Medicare beneficiaries, totaling 2,963 services with total Medicare billing of $311,713. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Hialeah, FL
- Active Since 10/05/2005
- Last Updated 07/27/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1508853490
Products in Payments
- XIFAXAN (Drug) $2,008
- OCALIVA (Drug) $982.41
- STELARA (Biological) $857.01
- IBSRELA (Drug) $460.31
- Prolastin-C Liquid (Biological) $445.38
- REMICADE (Biological) $424.19
- SUCRAID (Drug) $418.87
- TRULANCE (Drug) $393.64
- HUMIRA (Biological) $375.82
- Humira (Biological) $354.20
- XIFAXANIBSD (Drug) $286.46
- MOVIPREP (Drug) $280.20
- RINVOQ (Biological) $274.92
- MAVYRET (Drug) $255.93
- Sucraid (Drug) $253.81
- Talicia (Drug) $216.16
- ZENPEP (Drug) $209.41
- CLENPIQ (Drug) $191.54
- SKYRIZI (Biological) $187.00
- IRRISEPT (Device) $181.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Hialeah
Mr. Joel Kertznus, M.d, M.D
Gastroenterology — Payments: $72,665
Dr. Manuel Gonzalez, M.d, M.D
Gastroenterology — Payments: $46,485
Dr. Orlando Torres, M.d, M.D
Gastroenterology — Payments: $35,507
Dr. Juan Blum Guzman, M.d, M.D
Gastroenterology — Payments: $11,164
Jorge Castaneda, M.d, M.D
Gastroenterology — Payments: $10,428
Vanessa Mendez, M.d, M.D
Gastroenterology — Payments: $10,014